Skip to main content

Celldex Therapeutics, Inc 10-Q for FY2023 Q2

Celldex Therapeutics, Inc. (CLDX)

10-Q 2023-08-08 For: 2023-06-30
View Original
Added on April 04, 2026

About this 10-Q

Celldex Therapeutics, Inc filed this 10-Q on August 8, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).

Headline figures

Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$268K
up 64.4% from $163K a year earlier
Diluted EPS
-$0.65
compared with -$0.77 a year earlier